Measuring quality of life: impact of chemotherapy for advanced colorectal cancer. Experience from two recent large phase III trials.


When assessing the value of a particular treatment, it is important to consider the impact it may have on the quality of life of those being treated. This is particularly so for cancer patients, whose life expectancy may be short. Patients with advanced colorectal cancer who participated in two international comparative studies of raltitrexed ('Tomudex') vs… (More)
DOI: 10.1038/bjc.1998.420


6 Figures and Tables